Senior insider sale
Chief Executive Officer at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$1.76M
540.44K shares
GIBSON CHRISTOPHER plans to sell 540.44K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $1.76M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Restricted Stock Vesting Compensation | 56.27K | — |
2/15/2026 | Restricted Stock Vesting Compensation | 64.84K | — |
2/6/2026 | Restricted Stock Vesting Compensation | 19.98K | — |
11/15/2025 | Restricted Stock Vesting Compensation | 51.72K | — |
8/15/2025 | Restricted Stock Vesting Compensation | 51.72K | — |
5/15/2025 | Restricted Stock Vesting Compensation | 55.91K | — |
| Total | 300.44K | ||
Completed
Units to sell
40K
Market value
$144.8K
Units to sell
40K
Market value
$123.2K
Units to sell
40K
Market value
$134.8K
Units to sell
40K
Market value
$144.4K
Units to sell
40K
Market value
$124.0K
Units to sell
40K
Market value
$130.0K
Planned — Approximate Date
Units to sell
300.44K
Market value
$962.3K
Units
540.44K
Value
$1.76M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/5/2026 | 40K | $144.8K | — | Completed |
5/22/2026 | 40K | $123.2K | — | Completed |
5/7/2026 | 40K | $134.8K | — | Completed |
4/22/2026 | 40K | $144.4K | — | Completed |
4/7/2026 | 40K | $124.0K | — | Completed |
3/23/2026 | 40K | $130.0K | — | Completed |
| Planned — Approximate Date | ||||
6/18/2026 | 300.44K | $962.3K | NASDAQ | Planned |
| Total | 540.44K | $1.76M | ||